McKesson Corporation $MCK Shares Sold by Firetrail Investments PTY Ltd.

Firetrail Investments PTY Ltd. lessened its holdings in shares of McKesson Corporation (NYSE:MCK) by 3.4% in the third quarter, HoldingsChannel.com reports. The firm owned 24,520 shares of the company’s stock after selling 851 shares during the period. McKesson comprises 4.7% of Firetrail Investments PTY Ltd.’s holdings, making the stock its 5th largest position. Firetrail Investments PTY Ltd.’s holdings in McKesson were worth $18,798,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in MCK. Solstein Capital LLC boosted its holdings in shares of McKesson by 171.4% in the 2nd quarter. Solstein Capital LLC now owns 38 shares of the company’s stock worth $28,000 after buying an additional 24 shares during the last quarter. State of Wyoming bought a new stake in McKesson in the second quarter worth about $29,000. Abound Wealth Management boosted its stake in McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after acquiring an additional 24 shares during the last quarter. Delos Wealth Advisors LLC bought a new position in shares of McKesson during the 2nd quarter valued at approximately $35,000. Finally, Lynch Asset Management Inc. purchased a new stake in shares of McKesson during the 3rd quarter worth approximately $39,000. 85.07% of the stock is owned by institutional investors.

Trending Headlines about McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Q3 results beat consensus: EPS topped estimates and revenue grew ~11.4% year‑over‑year; management raised FY‑2026 adjusted EPS guidance to $38.80–$39.20, underpinning today’s rally. McKesson Q3 Earnings Call Highlights
• Positive Sentiment: Growth drivers called out on the call: oncology, specialty distribution and technology businesses accelerated, which McKesson cites as the basis for the raised profit outlook. MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
• Positive Sentiment: Strong market reaction: analysts and investors pushed the share price sharply higher on the beat + guidance, citing the bigger‑than‑expected lift to FY26 adjusted EPS. How McKesson Stock Surged 17% In A Day
• Neutral Sentiment: Analyst target changes mixed: some firms raised price targets (e.g., Wells Fargo, Mizuho) but ratings stayed neutral/equal‑weight, leaving upside expectations varied among brokers. Price Target Raised to $925.00 at Wells Fargo & Company
• Neutral Sentiment: Company materials and transcripts are available for detailed review (presentation and full earnings call transcript) — useful for checking segment KPIs, margin drivers and guidance assumptions. Q3 2026 earnings call transcript
• Negative Sentiment: Operational cash flow weakness flagged: some reports note weaker operating cash flow despite profit growth, and balance‑sheet metrics (higher liabilities) warrant watching for sustainability of buybacks/dividends. EPS Beats, Profit Growth but Weak Operating Cash Flow
• Negative Sentiment: Insider selling is noted in recent filings; combined with high share price momentum, this can contribute to near‑term volatility or profit‑taking. Insider Trading and Hedge Fund Activity

Analyst Ratings Changes

Several equities analysts have weighed in on MCK shares. Zacks Research lowered McKesson from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 25th. Evercore reaffirmed an “outperform” rating and set a $1,000.00 price target on shares of McKesson in a research report on Thursday, November 6th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of McKesson in a research note on Wednesday, December 10th. Mizuho boosted their price objective on McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Jefferies Financial Group upped their price objective on shares of McKesson from $820.00 to $900.00 and gave the company a “buy” rating in a report on Monday, October 13th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, McKesson presently has an average rating of “Moderate Buy” and an average price target of $918.93.

McKesson Trading Down 1.0%

MCK stock opened at $947.96 on Friday. The firm has a 50 day moving average of $828.41 and a 200-day moving average of $780.06. The firm has a market capitalization of $116.12 billion, a P/E ratio of 27.26, a price-to-earnings-growth ratio of 1.55 and a beta of 0.40. McKesson Corporation has a 12 month low of $583.55 and a 12 month high of $971.93.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion for the quarter, compared to analysts’ expectations of $105.98 billion. During the same period in the prior year, the company posted $8.03 EPS. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Sell-side analysts predict that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a dividend of $0.82 per share. This represents a $3.28 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s payout ratio is presently 9.43%.

Insiders Place Their Bets

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction dated Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president directly owned 2,268 shares in the company, valued at $1,851,096.24. This represents a 10.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.08% of the stock is owned by corporate insiders.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.